The global Mumps Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Mumps Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Mumps Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Mumps Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Mumps Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Beijing Minhai Biotechnology Co., Ltd
Beijing Tiantan Biological Products Co., Ltd.
China National Pharmaceutical Group Corporation
GlaxoSmithKline Plc
Organic Vaccines
Prometheon Pharma, LLC
Sinovac Biotech Ltd.
Zydus Cadila Healthcare Limited

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
RIT 4385
Schwarz
Wistar RA 27/3
Others

Segment by Application
Hospital
Clinic
Others